Most kids bounced back after COVID disruptions
Long-term research finds most children recovered from the effects of the pandemic.
We haven't written up this one. Futurity has the full story — the link below goes straight to it.
More in Health & Medicine
USPSTF's New Cardiologists; Wrist Nerve Stimulator for Afib; Doc Impaled by Tree
(MedPage Today) -- Cardiologists Ronald Karlsberg, MD, and Venkatesh Murthy, MD, PhD, are among the new appointees to the U.S. Preventive Services Task Force (USPSTF).
Celldex's hives drug faces safety questions despite Phase 3 successes
Celldex said its experimental treatment barzolvolimab hit its primary endpoint in two Phase 3 trials, even as the readout raised safety concerns on two life-threatening cases of allergic reaction…
CDSCO flags indiscriminate use of painkillers and antibiotics
The Drugs Controller General of India advises that all non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics must be sold and distributed only on the prescription of a registered medical…
Immune cells that may help sustain type 1 diabetes attack identified
Type 1 diabetes isn't an overnight attack against the body's ability to make insulin. It can be a sustained campaign over years that relentlessly targets insulin-producing cells in the pancreas.
Celldex sinks as safety concerns cloud immune drug results
Though barzolvolimab displayed what one analyst described as the best efficacy results to date against chronic skin hives, treatment was also associated with two life-threatening anaphylaxis cases.
This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month
Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock is soaring.